We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Enhanced ASGR2 by microplastic exposure leads to resistance to therapy in gastric cancer
Summary
Researchers fed polystyrene microplastics to mice and found that the particles accumulated in stomach tissue, where they triggered changes associated with more aggressive cancer behavior. In gastric cancer cells, microplastic exposure increased migration, induced drug resistance to multiple cancer therapies, and activated a gene called ASGR2 that appears to drive these effects. The study suggests that microplastic accumulation in the stomach may interfere with the effectiveness of cancer treatments.
<b>Background:</b> Microplastics (MPs) are a new global environmental threat. Previously, we showed the biodistribution of MPs using [<sup>64</sup>Cu] polystyrene (PS) and PET in mice. Here, we aimed to identify whether PS exposure has malignant effects on the stomach and induces resistance to therapy. <b>Methods:</b> BALB/c nude mice were fed 1.72 × 10<sup>4</sup> particles/mL of MP. We investigated PS accumulation in the stomach using radioisotope-labeled and fluorescent-conjugated PS. Further, we evaluated whether PS exposure induced cancer stemness and multidrug resistance, and whether it affected tumor development, tumor growth, and survival rate <i>in vivo</i> using a 4-week PS-exposed NCI-N87 mouse model. Using RNA-Seq analysis, we analyzed whether PS exposure induced gene expression changes in gastric tissues of mice. <b>Results:</b> PET imaging results showed that a single dose of [<sup>64</sup>Cu]-PS remained for 24 h in the mice stomach. The 4-week daily repetitive dose of fluorescent conjugated PS was deposited in the gastric tissues of mice. When PS was exposed, a 2.9-fold increase in migration rate was observed for NCI-N87 cells. Immunocytochemistry results showed decreased E-cadherin and increased N-cadherin expression, and flow cytometry, qPCR, and western blot analysis indicated a 1.9-fold increase in N-cadherin expression after PS exposure<b>.</b> Further, PS-induced multidrug resistance to bortezomib, paclitaxel, gefitinib, lapatinib, and trastuzumab was observed in the NCI-N87 mouse model due to upregulated CD44 expression. RNA-seq results identified increased asialoglycoprotein receptor 2 (<i>ASGR2</i>) expression after PS exposure, and <i>ASGR2</i> knockdown decreased cell proliferation, migration, invasion, and drug resistance. <b>Conclusion:</b> We demonstrated that <i>ASGR2</i> enhanced cancer hallmarks on PS exposure and induced resistance to chemo- and monoclonal antibody-therapy. Our preclinical findings may provide an incentive for further epidemiological studies on the role of MP exposure and its association with gastric cancer.
Sign in to start a discussion.